AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MYGN
  4. [SCHEDULE 13G/A] Myriad Genetics Inc SEC Filing

[SCHEDULE 13G/A] Myriad Genetics Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock MYGN logo
Myriad Genetics

NASDAQ:MYGN

MYGN Rankings

#4892 Ranked by Market Cap
N/A Ranked by Dividends
#8 Top Gainer

MYGN Latest News

Aug 5, 2025
Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum
Jul 31, 2025
Myriad Genetics Announces New $200 Million Credit Facility
Jul 29, 2025
Myriad Genetics to Release Second Quarter 2025 Financial Results聽on August 5, 2025
Jul 15, 2025
Myriad Genetics Earns 2025 Great Place To Work Certification鈩�
Jun 3, 2025
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen

MYGN Latest SEC Filings

Aug 6, 2025
[10-Q] Myriad Genetics Inc Quarterly Earnings Report
Aug 5, 2025
[8-K] Myriad Genetics Inc Reports Material Event
Aug 4, 2025
[SCHEDULE 13G/A] Myriad Genetics Inc SEC Filing
Jul 31, 2025
[8-K] Myriad Genetics Inc Reports Material Event
Jul 29, 2025
[SCHEDULE 13G/A] Myriad Genetics Inc SEC Filing

MYGN Stock Data

360.41M
89.18M
2.77%
103.48%
8.2%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
United States
SALT LAKE CITY